Coca-Cola FEMSA, S.A.B. de C.V. (KOF)
NYSE: KOF · Real-Time Price · USD
83.43
+0.39 (0.47%)
Aug 1, 2025, 4:00 PM - Market closed
Verve Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$105.50
Upside
+26.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $105 → $100 | Buy | Maintains | $105 → $100 | +19.86% | Jul 31, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $111 → $107 | Hold | Maintains | $111 → $107 | +28.25% | Jul 16, 2025 |
| UBS | UBS | Strong Buy Maintains $109 → $113 | Strong Buy | Maintains | $109 → $113 | +35.44% | Jul 8, 2025 |
| UBS | UBS | Strong Buy Maintains $106 → $109 | Strong Buy | Maintains | $106 → $109 | +30.65% | May 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $107 → $110 | Buy | Maintains | $107 → $110 | +31.85% | Apr 11, 2025 |
| Barclays | Barclays | Buy Maintains $99 → $105 | Buy | Maintains | $99 → $105 | +25.85% | Mar 4, 2025 |
| Barclays | Barclays | Buy Maintains $110 → $108 | Buy | Maintains | $110 → $108 | +29.45% | Oct 30, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $93 → $102 | Hold → Strong Buy | Upgrades | $93 → $102 | +22.26% | Oct 29, 2024 |
| Barclays | Barclays | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +31.85% | Jul 31, 2024 |
| Barclays | Barclays | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +25.85% | Jul 15, 2024 |
| UBS | UBS | Strong Buy Maintains $112 → $102 | Strong Buy | Maintains | $112 → $102 | +22.26% | Jul 10, 2024 |
| UBS | UBS | Strong Buy Maintains $109 → $112 | Strong Buy | Maintains | $109 → $112 | +34.24% | Apr 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $102 → $107 | Buy | Maintains | $102 → $107 | +28.25% | Apr 12, 2024 |
| Scotiabank | Scotiabank | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Apr 12, 2024 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Feb 2, 2024 |
| UBS | UBS | Hold → Strong Buy Upgrades $83 → $109 | Hold → Strong Buy | Upgrades | $83 → $109 | +30.65% | Jan 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.